Search Results
Slidesets
Epidemiological study of Doravirine associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy - Anne-Geneviéve Marcelin
Presented at:
European Meeting on HIV & Hepatitis 2019
Slidesets
Clinical progress of the entry inhibitor Myrcludex B | Stephan Urban
Presented at:
International Workshop on HBV Cure 2018
Slidesets
Baseline Resistance-Guided Therapy Does Not Enhance the Response to Interferon-Free Treatment of HCV Infection in Real Life | Luis M. Real
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Experiencia con Inhibidores de la Integrasa en un hospital terciario- I. Mur
Presented at:
Spanish HIV Clinical Forum 2017
Slidesets
Dual therapy regimens | Maria Ines Figueroa, MD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
Update on HIV drug resistance - Jonathan Schapiro, MD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2014
Slidesets
Transmitted Drug Resistance to Integrase Based First-Line Treatment in Europe, 2018-2021
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
The Health Outcomes Around Pregnancy and Exposure to HIV/ARVs (HOPE) Study: A Prospective Cohort of Reproductive-Aged Women Living With HIV
Presented at:
International Workshop on HIV & Women 2024
Slidesets
The Health Outcomes Around Pregnancy and Exposure to HIV ARVs (HOPE) Study - A Prospective Cohort of Reproductive-Aged Women Living With HIV.pdf
Presented at:
International Workshop on HIV & Women 2024